GLP-1 receptor agonists may enhance the effects of desmopressin in individuals with AVP deficiency: a case series and proposed mechanism
Our findings indicate a potential interaction between GLP-1 RAs and desmopressin in AVP-D. Clinicians should reassess desmopressin dosage upon initiating GLP-1 RA therapy.
Authors
- Bshara Mansour (ORCID: https://orcid.org/0000-0001-9420-9101)
- Afif Nakhleh (ORCID: https://orcid.org/0000-0003-1206-1516)
- Naim Shehadeh (ORCID: https://orcid.org/0000-0003-3158-6254)
Institutions
- Bar-Ilan University (IL)
- Rambam Health Care Campus (IL)
- Maccabi Healthcare Services (IL)
Publication Details
- Journal
- Pituitary
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1007/s11102-024-01451-7
- Citations
- 8
- Primary Topic
- Electrolyte and hormonal disorders
- Type
- article
- Field-Weighted Citation Impact
- 3.35
Funders
- Bar-Ilan University